Aurora Cannabis Inc.

ACB Healthcare Drug Manufacturers Specialty & Generic

Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.

3.99 0.11 −2.68%
Market cap
$265.8M
P/E
0.0×
Fwd P/E
−783×
Dividend yield
—
F-score
4/9
Altman Z
−12.34
Beneish M
−2.53
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
1.28 0.90 0.80 0.82
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(11.49) 19.22 (733.60) (53.59)
P/B ratio
0.82 0.59 0.50 0.45
Price to Tangible BV
0.92 0.66 0.56 0.51
EV/Sales
1.15 0.74 0.53 0.58
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
185.39 (28.81) (12.65) (5.95)
EV/FCF
(25.01) (9.25) (4.89) (3.35)
Quick Ratio
1.52 1.36 3.13 2.59
Current Ratio
3.41 3.06 5.94 5.36
Net Debt/EBITDA
4.15 (9.14) 13.80 34.68
Debt/Assets
12.52% 12.25% 3.02% 2.71%
Debt/Equity
0.17 0.17 0.04 0.03
Asset Turnover
0.46 0.46 0.44 0.40
Operating CF/Net income
0.78 9.54 0.01 1.10
Capex/Depreciation
(0.78) (1.22) 8.65 (1.10)
Interest Coverage
(8.37) 1.04 2.33 (18.82)
Research and Development Expense of Revenue
1.00% 1.38% 2.57% 3.75%
Selling, General and Administrative Expense of Revenue
51.75% 42.54% 107.67% 60.52%
Intangible Assets out of Total Assets
0.08 0.08 0.10 0.10
Share Based Compensation of Revenue
5.51% 2.35% (5.37%) 1.03%
Graham Net Nets
0.51 0.71 1.20 1.26
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(11.58%) (25.59%) (47.71%) (50.54%)
Free Cash Flow Yield
(3.59%) (8.89%) (13.64%) (20.98%)
Revenue per Share
1.16 1.19 0.49 0.79
Operating CF per Share
(0.52) 0.22 0.00 (0.05)
Capex per Share
(0.07) (0.07) (0.07) (0.06)
Free Cash Flow per Share
(0.59) 0.15 (0.08) (0.12)
Cash per Share
1.83 1.95 2.10 1.75
Shareholders Equity per Share
7.29 7.18 6.53 6.17
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
7.29 7.18 6.53 6.17
Free Cash Flow
(33.37) 8.67 (4.28) (7.12)
Working Capital
217.57 215.12 239.23 231.15
Capital Expenditures
(4.08) (3.78) (4.03) (3.91)
Net Current Asset Value
169.92 170.98 223.07 216.48
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.06 0.06 0.14 0.08
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
31.68 33.53 31.39 28.99
Average Payables
32.22 49.38 44.76 49.91
Average Inventory
158.33 173.40 149.28 150.25
Average Assets
571.12 587.49 523.94 527.11
Average Common Equity
419.49 422.34 403.93 403.18

Fold the line items

Columns are period end dates